Can-Fite BioPharma (CANF) Tax Rate (2017)
Can-Fite BioPharma (CANF) posted Tax Rate of 0.63% for Q4 2017.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Tax Rate (2017) Analysis & Trends
Can-Fite BioPharma (CANF) has 1 years of Tax Rate data on file, last reported at 0.63% in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.77 Bn | 631.01 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 447.56 Bn | 440.99 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 364.58 Bn | 357.44 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 268.98 Bn | 261.29 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 158.03 Bn | 146.33 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 52.29 Bn | 44.91 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - | - |
| 8 | Incyte | 25.12 Bn | 20.58 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 10.65% |
| 10 | Can-Fite BioPharma | 1.83 Mn | -1.16 Mn | - | - |